Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction-Reference-Cited by-同舟云学术

Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction

Published:2017-10-02 Issue:2 Volume:5 Page:262-270
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Yoshihisa Akiomi¹,Sato Yu¹,Yokokawa Tetsuro¹,Sato Takamasa¹,Suzuki Satoshi¹,Oikawa Masayoshi¹,Kobayashi Atsushi¹,Yamaki Takayoshi¹,Kunii Hiroyuki¹,Nakazato Kazuhiko¹,Saitoh Shu-ichi¹,Takeishi Yasuchika¹

Affiliation:

1. Department of Cardiovascular Medicine; Fukushima Medical University; 1 Hikarigaoka Fukushima 960-1295 Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies;Sharma;Circ Res,2014

2. Heart failure with preserved ejection fraction: a clinical dilemma;Komajda;Eur Heart J,2014

3. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation;Paulus;J Am Coll Cardiol,2013

4. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin;Zile;Circulation,2015

5. Myofibroblast-mediated mechanisms of pathological remodelling of the heart;Weber;Nat Rev Cardiol,2013

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Fetuin‐A Levels Are Associated With Exercise Intolerance and Predict the Risk of Adverse Outcomes in Patients With Heart Failure: The Role of Cardiac–Hepatic–Peripheral Interaction;Journal of the American Heart Association;2024-09-03

2. Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis;American Heart Journal;2024-09

3. Direct Bilirubin, but not Indirect Bilirubin, is Associated with Short-term Adverse Events in HFpEF;Current Gene Therapy;2024-08

4. Cardiac abnormalities pre- and post-liver transplantation for metabolic dysfunction-associated steatohepatitis – Evidence and special considerations;Journal of Liver Transplantation;2024-08

5. NAFLD is a predictor of high risk of development and a co-factor in the progression of cardiovascular diseases;South Russian Journal of Therapeutic Practice;2024-06-24